FDA Approved: TPOXX — Supplemental Application (SIGA Technologies, Inc.)

View source ↗

Summary

FDA approves a supplemental application for TPOXX (tecovirimat monohydrate) from SIGA Technologies, expanding its approved use for smallpox.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smallpox

Drugs mentioned

• TPOXX (tecovirimat monohydrate)

Snippet

SUPPL AP for TPOXX (TECOVIRIMAT MONOHYDRATE)